CDC26 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.759600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.573200E-01
Normal-vs-Stage2
9.794000E-01
Normal-vs-Stage3
5.835200E-01
Normal-vs-Stage4
7.803800E-01
Stage1-vs-Stage2
9.571600E-01
Stage1-vs-Stage3
4.660600E-01
Stage1-vs-Stage4
7.975600E-01
Stage2-vs-Stage3
3.589400E-01
Stage2-vs-Stage4
7.304600E-01
Stage3-vs-Stage4
3.592400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.725800E-01
Normal-vs-AfricanAmerican
5.086600E-01
Normal-vs-Asian
5.634000E-01
Caucasian-vs-AfricanAmerican
3.805400E-01
Caucasian-vs-Asian
3.756800E-01
AfricanAmerican-vs-Asian
8.110100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.202000E-01
Normal-vs-Female
9.432800E-01
Male-vs-Female
5.044400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.243200E-01
Normal-vs-Age(41-60Yrs)
7.792000E-01
Normal-vs-Age(61-80Yrs)
9.203200E-01
Normal-vs-Age(81-100Yrs)
7.170600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.220500E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.204090E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.916000E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.997360E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.469200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.943600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.602200E-01
Normal-vs-Daily Drinker
8.628200E-01
Normal-vs-Weekly Drinker
7.978400E-01
Normal-vs-Occasional Drinker
7.507800E-01
Normal-vs-Social Drinker
8.029800E-01
Non Drinker-vs-Daily Drinker
3.114400E-01
Non Drinker-vs-Weekly Drinker
9.650800E-01
Non Drinker-vs-Occasional Drinker
2.045600E-01
Non Drinker-vs-Social Drinker
9.483800E-01
Daily Drinker-vs-Weekly Drinker
4.446600E-01
Daily Drinker-vs-Occasional Drinker
8.298000E-01
Daily Drinker-vs-Social Drinker
4.433800E-01
Weekly Drinker-vs-Occasional Drinker
3.131800E-01
Weekly Drinker-vs-Social Drinker
9.868400E-01
Occasional Drinker-vs-Social Drinker
3.113800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.642200E-01
Normal-vs-Grade 2
8.618200E-02
Normal-vs-Grade 3
1.252990E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.995200E-01
Grade 1-vs-Grade 3
9.431000E-01
Grade 1-vs-Grade 4
2.642200E-01
Grade 2-vs-Grade 3
3.308600E-01
Grade 2-vs-Grade 4
8.618200E-02
Grade 3-vs-Grade 4
1.252990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.924400E-01
Normal-vs-NonDiabetic
9.282000E-01
Diabetic-vs-NonDiabetic
7.602400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.620400E-01
Normal-vs-NoPancreatitis
9.309800E-01
Pancreatitis-vs-NoPancreatitis
6.109800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.131800E-01
Normal-vs-N1
9.778800E-01
N0-vs-N1
7.748600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.408800E-01
Normal-vs-TP53-NonMutant
7.720200E-01
TP53-Mutant-vs-TP53-NonMutant
6.882200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
